CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 72 enrolled
Drug / intervention
Gabapentin +1 moredrug
Likely dose
Gabapentin 600 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04434430
NCT04434430Phase 2Completed
CompareCT.gov

Effectiveness of Preemptive Oral Gabapentin 600 mg on Morphine Requirement After Non Obstetric Lower Abdominal Surgery

Indonesia University·interventional·Posted Jun 16, 2020·Updated Sep 13, 2021

In Brief

A Phase 2 clinical trial evaluating Gabapentin and Placebo for Non-obstetric Lower Abdominal Surgery. Completed, enrolled 72 participants across 1 site.

Detailed Summary

This study aimed to get the information about the effectiveness of preemptive oral gabapentin 600 mg in reducing morphine requirement after non obstetric lower abdominal surgery

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNon-obstetric Lower Abdominal Surgery
CountriesIndonesia
Collaborators--

Timeline

Phase 2CompletedFinished
2020202120222023202420252026
First PostedJun 16, 2020
Enrollment StartNov 11, 2019
Primary CompletionFeb 29, 2020
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 6.0 years ago

Interventions

Gabapentindrug

Oral Gabapentin 600 mg

Placeboother

Oral NaCl 500 mg